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Abstract
Purpose We hypothesized that biomarkers and dietary factors related to cardiovascular disease risk were associated with 
serum retinol and evaluated these potential associations in patients with suspected coronary artery disease (CAD).
Methods We used cross-sectional data from 4116 patients hospitalised for suspected CAD. Dietary data were obtained from 
a subgroup of 1962 patients using a food frequency questionnaire. Potential biomarkers and dietary factors were explored 
using linear regression modelling adjusted for age and sex. Regression coefficients and corresponding confidence intervals 
(CI) are given as  % change in serum retinol per unit change in the predictors. Analyses were performed in the total popula-
tion and in strata of serum retinol tertiles.
Results In age- and sex-adjusted models, serum creatinine (standardized β: 0.38, 95% CI [0.35, 0.42]), plasma total cysteine 
(0.26, [0.23, 0.29]), serum uric acid (0.30, [0.26, 0.33]) and plasma neopterin (0.22, [0.18, 0.25]) were positively associ-
ated, whereas plasma serine (− 0.15, [− 0.18, − 0.12]) and serum C-reactive protein (− 0.15, [− 0.18, − 0.12]) were inversely 
associated with serum retinol. When we included the significant biomarkers in a multivariate model, the model explained 
33% of the variability (R2 = 0.33) in serum retinol. The results were similar in the lower and upper tertiles of serum retinol. 
Weak or no associations were observed for dietary factors.
Conclusions In patients with suspected CAD, concentrations of creatinine, cysteine and uric acid were positively associated 
with serum retinol. Future studies should assess whether retinol concentrations are influenced by metabolic alterations in 
patients at risk of cardiovascular disease.
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Introduction
Vitamin A is an essential, fat-soluble micronutrient that 
refers to all-trans retinol and its bioactive metabolites reti-
naldehyde, retinoic acid (RA) as well as retinyl ester and pro-
vitamin A carotenoids [1]. Following dietary intake from 
foods of plant and/or animal origin, retinol is transported as 
retinyl esters with triacylglycerol-rich chylomicrons to the 
liver where it can either be stored in hepatic stellate cells or 
exported to peripheral tissue bound to retinol-binding pro-
tein 4 (RBP4) and transthyretin. Retinol is then converted to 
RA in target tissues where it functions as a ligand for nuclear 
RA receptors with several target genes involved in growth 
and differentiation, metabolism of macronutrients [2], and 
the immune system [3].
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We have recently reported that elevated serum retinol 
potentiates the risk of incident acute myocardial infarctions 
associated with traditional risk markers in subjects hos-
pitalised for suspected coronary artery disease, including 
lipids and total homocysteine [4, 5]. The circulating retinol 
concentrations in these patients exceed those reported from 
other cohorts [6–9], and retinol concentrations above clinical 
reference ranges have been associated with the metabolic 
syndrome [10] and cardiovascular disease (CVD) [11]. In 
addition, plasma concentrations of RBP4, which circulates 
with retinol in a nearly 1:1 manner, were elevated in condi-
tions characterized by metabolic dysfunction such as diabe-
tes type 2 [12], obesity [13] and atherosclerosis [14].
In spite of these recent observations, biomarkers associ-
ated with circulating retinol concentrations have not been 
well characterized in populations with CVD. Although early 
findings suggest that serum retinol is under tight homeostatic 
control except during conditions of deficiency or extreme 
excess [15], recent reports suggest that patients with chronic 
kidney disease have higher [16], whereas inflammation may 
reduce [17] serum retinol. Thus, the aim of this exploratory 
cross-sectional study was to identify biomarkers and dietary 
factors associated with serum retinol in a large cohort of 
patients with suspected or established CVD. Our focus was 
primarily on biomarkers relevant for CVD risk including 
circulating lipid parameters, homocysteine and inflamma-
tory markers, as well as dietary factors and kidney func-
tion. Analyses were conducted for the total population and 




The study population has been described extensively else-
where [18]. Briefly, 4164 patients were initially included 
in this study. All patients were recruited upon planned 
angiography for suspected stable angina pectoris at Hauke-
land (n = 3413) and Stavanger (n = 751) University Hos-
pitals, Norway and 61.8% (n =2573) were enrolled in the 
Western Norway B-vitamin Intervention Trial (WENBIT) 
(clinicaltrials.gov: NCT00354081) [19]. The main aim of 
the WENBIT was to address the effect of homocysteine-
lowering therapies with B-vitamins on a composite out-
come consisting of all-cause death, nonfatal acute myo-
cardial infarction, acute hospitalization for unstable stable 
angina pectoris and nonfatal thromboembolic stroke. Data 
were collected between 2000 and 2004. Patients with 
missing data on serum retinol (n = 46) and with extremely 
low (< 0.8 μmol/L) (n =1) or high (> 9.0 μmol/L) (n = 1) 
concentrations of retinol were excluded from the study, 
yielding a total of 4116 eligible patients for analysis. 
Informed consent, ethical approval, and necessary per-
missions from the Norwegian Medicines Agency and the 
Norwegian Data Inspectorate were obtained. The study 
was carried out according to the Declaration of Helsinki.
Baseline data, biochemical analyses and food 
frequency questionnaire
Acquisition of clinical and diagnostic data including 
information on the presence and extent of coronary artery 
stenosis as determined by coronary angiography, body 
composition and smoking habits have been described in 
detail previously [18]. In addition, mostly non-fasting 
blood samples (80%) were collected at baseline and serum 
samples were stored at − 80 °C until analysis. Plasma con-
centrations of methionine, total homocysteine, cystathio-
nine and cysteine were analysed using gas chromatogra-
phy-mass spectrometry [20, 21], whereas serum all-trans 
retinol [22], creatinine [23] and plasma neopterin [24] 
were measured by high-performance liquid chromatogra-
phy/tandem mass spectrometry. Kynurenine, tryptophan, 
4-pyridoxic acid (PA), pyridoxal (PL) and pyridoxal-
5-phosphate (PLP) were measured by liquid chromatog-
raphy/tandem mass spectrometry [24]. Kynurenine to tryp-
tophan ratio (KTR) and the PA-ratio (PAr; PA/PL + PLP) 
were calculated, and both have been proposed as markers 
of inflammation [25, 26]. All of the above measurements 
were performed in collaboration with Bevital AS, a com-
pany specializing in the assessment of biomarkers related 
to nutritional status and inflammation (http://www.bevit 
al.no). Concentrations of fibrinogen, total cholesterol, 
apolipoprotein A1 and B, C-reactive protein (CRP), and 
dietary vitamin A intake were measured as described pre-
viously [4, 18, 27]. Serum uric acid measurements were 
part of the routine laboratory analytical panel [18].
Baseline dietary data were obtained from 2068 
WENBIT participants from a 169-items food frequency 
questionnaire (FFQ). After exclusion due to noncom-
pletion of the FFQ, very high (> 15,000  kJ/day for 
females, > 17,500 kJ/day for males) or very low energy 
intake (< 3000 kJ/day for females, 3500 kJ/day for males), 
1962 patients were eligible for analysis. The develop-
ment of the FFQ has been described elsewhere and has 
been validated for total energy intake and several nutri-
ents [28–30]. Frequency of consumption and measures 
were converted by a conversion system developed by the 
Department of Nutrition, University of Oslo (Kostbereg-
ningssystem, version 3.2; University of Oslo). Vitamin 
A intake is given as retinol activity equivalents (RAE), 
and conversion values are based on the official Norwegian 
Food Table.
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Statistical analysis
The majority of the continuous data were not normally 
distributed. Log-transformed continuous variables are, 
therefore, presented as geometric means (gM) (geometric 
standard deviations [gSD]). Intake data on macronutrients 
are presented as the proportion of total energy intake (E %), 
and food items as densities (g/1000 kcal). Vitamin A intake 
is given as RAE/1000 kcal. Categorical variables are given 
as n (%). Baseline characteristics are given for the total 
population.
We used ordinary least squares regression to evaluate 
individual predictors of log-transformed concentrations 
of serum retinol. All models were adjusted for age (con-
tinuous) and sex (categorical) unless otherwise specified, 
and plasma/serum predictors were log-transformed. Mod-
els including dietary intakes were additionally adjusted for 
energy intake. No data transformation was applied to the 
dietary data. Estimates are reported as standardized β which 
indicate the standard deviation change in serum retinol per 
standard deviation change in the exposure variable, which is 
equivalent to the partial correlation coefficient.
For the sake of interpretability, we also report unstand-
ardized βs (95% confidence interval). In models where the 
exposure and outcomes are log-transformed, the βs represent 
the  % change in serum retinol indicated by 1% increase in 
the exposure variable, respectively. These were subsequently 
multiplied by ten, and thus represent the  % change in serum 
retinol indicated by 10% increase in the exposure variable. 
For models including dietary data, the β represents the  % 
change in serum retinol indicated by 1 E % (macronutrients), 
50 g/1000 kcal (food groups) or 200 RAE/1000 kcal. Addi-
tionally, we calculated the adjusted R2 to obtain the variance 
explained by each model. The linearity of associations was 
visualized using generalized additive model (GAM) plots. 
After Bonferroni adjustment, p < 0.001 was considered sta-
tistically significant. Finally, all variables associated with 
serum retinol after Bonferroni adjustment were included in 
a single model and the adjusted R2 was calculated. Statistical 
analyses were performed using R version 3.6.1 and packages 
included in the “tidyverse” as well as “sjstats”. All figures 
were made with the “ggplot2” package.
Results
Baseline characteristics
Baseline characteristics and dietary intake for the total pop-
ulation are presented in Table 1 and 2. Serum concentra-
tions of retinol ranged from 1.02 to 7.65 μmol/L, and the 
gM (gSD) was 2.84 (1.26) μmol/L. The cohort consisted 
of 71.9% men, and gM (gSD) age was 60.8 (1.19) years, 
BMI was 26.5 (1.16) kg/m2 and creatinine was 90.2 (1.22) 
μmol/L. A total of 25.9% were smokers, whereas 74.8% had 
significant coronary stenosis at baseline angiography. For 
the 1962 patients that completed the FFQ, mean (SD) energy 
intake was 2073 (694) kcal whereas vitamin A intake was 
945 (606) RAE/1000 kcal/day.
Biomarkers associated with retinol in the total 
population
All analyses are presented in Fig. 1. Regression coefficients 
and their confidence intervals are given in Table 3. The strong-
est associations were found for serum creatinine, uric acid, 
triglycerides and plasma total cysteine, all of which were posi-
tively associated with serum retinol. Other positively asso-
ciated biomarkers included plasma neopterin, plasma total 
homocysteine and serum apolipoprotein A1. Negatively asso-
ciated biomarkers included CRP and plasma serine. Because 
Table 1  Baseline characteristics of the total population (n = 4116)
Baseline characteristics of the total population. Continuous variables 
are presented as geometric means and geometric standard deviations. 
Categorical variables are presented as count and per cent
Retinol, μmol/L 2.80 (1.26)
Age, years 60.8 (1.20)
Male sex, n (%) 2997 (71.9)
Smokers, n (%) 1321 (31.7)
Body mass index, kg/m2 26.5 (1.16)
Lipid parameters
 Apolipoprotein B, g/L 0.87 (1.31)
 Apolipoprotein A1, g/L 1.29 (1.23)
 Triglycerides, mmol/L 1.54 (1.67)
Homocysteine metabolism, μmol/L
 Methionine 27.0 (1.30)
 Total homocysteine 10.7 (1.38)
 Cystathionine 0.28 (1.81)




 C-reactive protein, mg/mL 3.64 (2.43)
 Uric acid, μmol/L 347 (1.28)
 Neopterin, nmol/L 8.57 (1.47)




 1–3 stenotic vessels, n (%) 3120 (74.9)
 Previous acute myocardial infarction, n (%) 1680 (40.3)
 Ejection fraction < 60%, n (%) 3277 (78.7)
Kidney function
 Creatinine, μmol/L 90.2 (1.22)
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serum creatinine is used as a marker of kidney function, which 
may confound associations between biomarkers and serum 
retinol in the circulation, additional models were created and 
adjusted for serum creatinine. The results remained particu-
larly for plasma total cysteine (standardized β = 0.17, 95% CI: 
0.13, 0.20, p < 0.001), serum uric acid (standardized β = 0.20, 
95% CI: 0.17, 0.24, p < 0.001) and plasma serine (standard-
ized β = − 0.11, 95% CI: − 0.14, − 0.07) and serum retinol, 
whereas the remaining associations were severely attenuated 
(data not shown). 
We evaluated the linearity of the associations by fitting 
GAM-curves for the associations of serum creatinine, uric 
acid, plasma total cysteine and serine with serum retinol as 
shown in Fig. 2. All associations appeared to be linear.
To assess the fraction of variance explained by all associ-
ated biomarkers after Bonferroni adjustment, we included 
age, sex, serum creatinine, total cholesterol, apolipoprotein 
A1 and B, triglycerides, uric acid and CRP, and plasma total 
homocysteine, cystathionine, total cysteine, serine, KTR, 
PAr, fibrinogen and neopterin in a multivariate regression 
model and calculated the adjusted R2. The total proportion of 
variance explained was 33%, and the predicted vs. observed 
values of log-transformed retinol based on this model are 
illustrated in Fig. 3.
Associations between dietary intakes and serum 
retinol
In total, 1962 patients completed the FFQ, and associa-
tions of dietary factors and retinol in serum are presented 
in Table 4. A weak, positive association was observed for 
meat and vegetable intake with serum retinol, whereas no 
particular associations were observed for other dietary vari-
ables including energy-adjusted RAE intake.
Factors associated with retinol in patients with low 
and high concentrations
Because of the substantial range in serum concentrations 
of retinol (1.02–7.65 μmol/L) we explored potential predic-
tors, separately in patients in the lower and higher ranges 
of serum retinol. Results according to serum retinol tertiles 
are presented in Figs. 4 and 5. Results from the 1st and 
3rd tertile (retinol < 2.57 and > 3.08 μmol/L, respectively) 
showed generally the same, but slightly weaker associations 
as for the total population. Associations for serum creatinine, 
plasma total cysteine and serum uric acid remained promi-
nent in the 1st and 3rd tertiles. The associations for dietary 
Table 2  Baseline nutrient and food intake
Baseline mean and standard deviation intake of nutrients and food 
groups
 Nutrients, E % Mean (SD)
 Vitamin A, RAE/1000 kcal 945 (606)
 Protein 16.7 (2.55)
 Carbohydrate 48.9 (6.46)


































































Associations of biomarkers with serum retinol 
 Total population
Fig. 1  Forest plot of predictors of serum retinol. The standardized 
β and corresponding confidence intervals were derived from linear 
regression models adjusted for age and sex. CRP C-reactive pro-
tein, apo apolipoprotein, KTR kynurenine to tryptophan ratio, PAr 
pyridoxic acid to pyridoxal + pyridoxal-5-phosphate ratio, BMI body 
mass index
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intakes with serum retinol were essentially similar for the 
total population (data not shown).
Discussion
Principal findings
Serum retinol has generally been considered to be under 
tight homeostatic control [15], and we have previously 
shown that retinol in serum of patients hospitalised for sus-
pected coronary artery disease may range beyond what has 
been observed in other cohorts [4–9]. Factors associated 
with this variation have not been elucidated to a meaningful 
extent in CVD patients. In this exploratory study, we report 
observed associations for circulating and dietary factors with 
serum retinol in a large cohort of patients with suspected 
coronary artery disease. The most prominent associations 
were observed for creatinine, triglycerides, uric acid, serine 
and the sulphur amino acid cysteine. When we adjusted for 
serum creatinine, several of the associations were attenuated, 
whereas those of total cysteine and uric acid with serum 
retinol remained. Other positively associated biomarkers 
included plasma neopterin, but this association was attenu-
ated after adjustment for creatinine. With the exception of 
meat and vegetable consumption, we found no particular 
associations between dietary intakes and serum retinol.
Serum creatinine and retinol
We observed a positive association between serum creati-
nine, a marker of kidney function, and serum retinol. This is 
in line with previous findings showing that retinol in serum 
increases in chronic kidney disease [16, 31] and that esti-
mated glomerular filtration rate is an important determinant 
of retinol in an elderly population [32]. One case–control 
study found that serum retinol was positively associated 
with hypertension, and the authors speculate that this effect 
might have been mediated by kidney dysfunction [33]. How-
ever, because the RBP4-retinol-transthyretin complex is too 
large to be filtered, the kidneys are not considered to be an 
important route of retinol excretion [1]. The association 
between serum creatinine and retinol may thus be affected 
by other factors, and not increased renal retention. One study 
Table 3  Regression coefficients 
and confidence intervals for 
biomarkers associated with 
retinol
Regression coefficients for various predictors. All models were adjusted for age and sex. Coefficients rep-
resent the percentage change in retinol per 10% increase in the predictor and the adjusted R2 represents the 
predictive power of the models
PAr 4-pyridoxic acid/pyridoxal + pyridoxal-5-phophate ratio, KTR kynurenine/tryptophan ratio
Standardized β (95% CI) β per 10% increase (95% CI) p value Adjusted R2 (%)
Lipid parameters
 Total cholesterol 0.14 (0.11, 0.17) 1.47 (1.15, 1.8) < 0.001 2.17
 Apolipoprotein B 0.14 (0.11, 0.17) 1.37 (1.04, 1.51) < 0.001 2.36
 Apolipoprotein A1 0.21 (0.18, 0.24) 2.44 (2.12, 2.81) < 0.001 4.36
 Triglycerides 0.26 (0.23, 0.29) 1.22 (1.10, 1.32) < 0.001 7.08
Homocysteine metabolism
 Methionine − 0.04 (− 0.07, − 0.01) − 0.36 (− 0.62, − 0.11) 0.007 0.44
 Total homocysteine 0.21 (0.18, 0.24) 1.52 (1.29, 1.75) < 0.001 4.29
 Cystathionine 0.19 (0.16, 0.23) 0.76 (0.21, 0.52) < 0.001 3.80
 Total cysteine 0.26 (0.23, 0.29) 4.81 (4.21, 5.32) < 0.001 7.11
 Serine − 0.15 (− 0.18, − 0.11) − 1.52 (− 1.88, − 1.17) < 0.001 2.17
 Glycine 0.00 (− 0.03, 0.30) 0.03 (− 0.27, 0.31) 0.823 0.30
Inflammation
 C-reactive protein − 0.15 (− 0.18, − 0.12) − 0.41 (− 0.49, − 0.32) < 0.001 2.50
 Uric acid 0.30 (0.26, 0.33) 2.81 (2.52, 3.23) < 0.001 9.71
 Neopterin 0.22 (0.18, 0.25) 1.43 (1.21, 1.62) < 0.001 4.34
 PAr 0.12 (0.08, 0.15) 0.60 (0.43, 0.76) < 0.001 1.53
 KTR 0.15 (0.12, 0.19) 1.14 (0.90, 1.38) < 0.001 2.35
 Fibrinogen − 0.07 (− 0.10, − 0.04) − 0.83 (− 1.25, − 0.42) < 0.001 0.70
Body mass
 Body mass index 0.06 (0.029, 0.09) 0.97 (0.47, 1.47) 0.013 0.60
Kidney function
 Creatinine 0.38 (0.35, 0.42) 4.51 (4.19, 4.93) < 0.001 14.5
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suggests that elevated retinol in kidney dysfunction is due 
to disrupted signalling pathways that increase retinol release 
from liver storage when kidney function is compromised 
[16], indicating that metabolic alterations may affect vita-
min A homeostasis with unknown consequences in patients 
with CVD.
Plasma cysteine, serine and serum retinol
To our knowledge, this is the first study demonstrating 
associations of plasma total cysteine and serine with serum 
retinol. In metabolism, serine is produced from glycolysis, 
serve as a precursor for glycine [34], and may condense 
with homocysteine to produce cystathionine and ultimately 
cysteine in transsulfuration [35, 36]. In observational stud-
ies, plasma serine and total cysteine were inversely and 
positively associated to components of the metabolic syn-
drome, respectively [37–40]. Because there is little literature 
available on the possible relationship between cysteine and 
serine with retinol, it is difficult to interpret the direction 
of the observed associations in the present study, but some 
evidence from other populations with lifestyle diseases sug-
gest that retinol may affect the metabolism of these amino 
acids. Notably, higher circulating concentrations of retinol 
bound to RBP4 may be associated with dysregulated glucose 
metabolism [12] which can impact serine production from 
glycolysis and partly explain the observed inverse associa-
tion between serine and retinol. Furthermore, animal models 
have demonstrated that enzymes involved in homocysteine 
and cysteine metabolism can be induced by RA administra-
tion [41–43]. Interestingly, both serine—as a glycine pre-
cursor—and cysteine are central to the hepatic formation of 
glutathione [35, 36, 44] a major antioxidant of which plasma 
concentrations can be low in subjects with obesity and CVD 
[45, 46]. Whether the possible effects of retinol on serine 
and cysteine influence glutathione status is not known, and 
future studies should thus seek to address whether elevated 
cysteine and reduced serine in lifestyle disease and CVD (1) 
reflect reduced glutathione synthesis and (2) whether this 
effect is mediated by the bioactive RA.
Inflammatory markers and serum retinol
Studies on the relationship between inflammation and vita-
min A are extensive [3, 17, 47]. Markers of the acute phase 
response, such as CRP, are inversely related to retinol [17]. 
It is generally accepted that systemic inflammation may con-
tribute to increased sequestration of retinol in tissues and 
subsequently to reduced serum concentrations. In line with 
this notion, we observed an inverse association between CRP 
and retinol. In contrast, other inflammatory markers associ-
ated with CVD risk, such as uric acid [48], were positively 
associated with serum retinol. This particular finding reflects 
Fig. 2  Generalized additive model plots of the age and sex-adjusted 
linear association between selected predictors and log-transformed 
serum retinol
Fig. 3  Observed vs. predicted values of log-transformed serum reti-
nol derived from a linear regression model including age, sex, total 
cysteine, uric acid, creatinine, neopterin, total cholesterol, apolipo-
protein A1 and B, triglycerides, total homocysteine and cystathionine, 
fibrinogen, pyridoxic acid to pyridoxal + pyridoxal-5-phosphate ratio 
and kynurenine to tryptophan ratio
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those of others, which have shown a positive association 
between uric acid and retinol in large and healthy cohorts 
[49, 50]. There may be several potential unmeasured fac-
tors that affect this association, but interestingly, the enzyme 
that produce uric acid—xanthine oxidase—has been linked 
to endothelial dysfunction in atherosclerosis [51] and can 
also catalyse the formation of RA [52]. Further, neopterin, 
a marker of the pro-atherogenic  Th1 cell-mediated mono-
cyte activation that has been linked CVD risk [53, 54] was 
positively associated with retinol in the present investigation. 
It is not known whether neopterin itself affects retinol con-
centrations, however, in vitro studies show that RA admin-
istered in physiological doses activate  Th1 cells [47] which 
in turn can contribute to proliferation of monocytes into 
macrophages and increased neopterin concentrations [53]. 
Our findings indicate a potential interplay between inflam-
matory processes in atherosclerosis and retinol and should 
be addressed in future studies. Specifically, the uptake and 
metabolism of retinol and activity of RA in immune cells 
during inflammatory processes specific to atherosclerosis 
would provide insight in this context.
Diet and serum retinol
The observed associations for the dietary predictors were 
weak, which is not unexpected considering the relatively sta-
ble concentrations of circulating retinol [55, 56]. Although 
the existing evidence for the association for meat intake 
and retinol is somewhat conflicting [57, 58] we did observe 
positive association between meat intake and serum retinol. 
Meat (in particular processed meat) intake should be limited 
in the context of CVD prevention [59] and taken together 
with the other results of the present investigation indicate 
that high serum concentrations of retinol at least in part are 
explained by factors related to an unfavourable risk profile 
in these patients. We cannot exclude the possibility that the 
bias present in dietary assessment tools obscured the true 
associations.
Strengths and limitations
The major strength of our study was the large, well-charac-
terized cohort including more than 4000 patients, the major-
ity with angiographically verified coronary artery disease, 
which provided a solid basis for the evaluation of biomarkers 
and dietary factors associated with serum retinol. However, 
our findings cannot be generalized beyond the study popula-
tion, because serum concentrations of retinol appear to be 
elevated in patients with CVD compared to a presumably 
healthy population residing in the same geographical area 
[60]. Further limitations include the cross-sectional design, 
which complicates the interpretation of the direction of the 
associations. Moreover, at this point the clinical implications 
are limited because many of the results presented here are 
novel, and relevance is difficult to establish until results are 
replicated in other cohorts. The interpretation of the asso-
ciations between total cysteine and uric acid with retinol 
was particularly complicated because it is unclear whether 
cysteine and uric acid affect retinol or vice versa.
Table 4  Regression coefficients and confidence intervals for dietary predictors of serum retinol
Regression coefficients for various dietary predictors. All models were adjusted for age, sex and energy intake. Coefficients represent the per-
centage change in vitamin A per 10% increase in the predictor and the adjusted R2 represents the predictive power of the models
Macronutrients Standardized β (95% CI) β per E % (95% CI) p value Adjusted R2 (%)
Protein 0.063 (0.02, 0.11) 0.52 (0.16, 0.89) 0.005 1.10
Carbohydrate − 0.062 (− 0.11, − 0.018) − 0.21 (− 0.36, − 0.07) 0.004 1.18
Total fat 0.002 (− 0.041, 0.045) − 0.02 (− 0.19, 0.14) 0.77 0.70
PUFA − 8e− 04 (− 0.045, 0.043) − 0.11 (− 0.58, 0.36) 0.65 0.79
MUFA 0.022 (− 0.022, 0.065) 0.15 (− 0.31, 0.61) 0.53 0.83
SFA − 0.0053 (− 0.048, 0.038) − 0.12 (− 0.47, 0.22) 0.48 0.81
Alcohol 0.077 (0.026, 0.13) 0.47 (0.15, 0.79) 0.004 1.01
Micronutrient β per 200 RAE/1000 kcal (95% CI)
 Vitamin A 0.017 (− 0.029, 0.062) 0.29 (− 0.03, 3.27) 0.09 0.80
Foods β per 50 g/1000 kcal (95% CI)
 Meat 0.076 (0.032, 0.12) 3.60 (1.54, 5.66) < 0.001 1.30
 Vegetables 0.04 (− 0.0033, 0.084) 0.91 (0.33, 1.50) 0.002 1.15
 Fruits and berries 0.005 (− 0.039, 0.049) 0.13 (− 0.41, 0.68) 0.63 0.70
 Eggs 0.012 (− 0.032, 0.056) 0.55 (− 7.13, 8.25) 0.89 0.70
 Dairy 0.048 (0.0048, 0.092) 0.41 (− 0.01, 0.82) 0.06 0.91
 Fish − 0.0068 (− 0.051, 0.037) − 0.02 (− 1.67, 1.61) 0.97 0.72
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It should be noted that the proportion of variance 
explained by the models was generally low. Overall, the 
adjusted R2 varied from 4 to ~ 15%, for the models, whereas 
a multivariate model including the most strongly associated 
biomarkers explained about 33% of the total variation in 
serum retinol. Although some of the unmeasured variations 
may be attributed to genetics [61, 62], we emphasize that 
very little is currently known about factors affecting reti-
nol in the circulation and that a continued effort should be 
undertaken to further explore this particular knowledge gap.
Conclusion
Biomarkers associated with retinol in patients with estab-
lished CVD include metabolites that are linked to meta-
bolic disease, kidney function, and inflammation. Future 
observational and experimental studies should assess the 
potential causal direction and the clinical relevance of 
these associations. Finally, it would be useful to assess 
these associations in healthy populations, to further 
uncover the role of retinol in health and disease.
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Associations of biomarkers with serum retinol 
 1st tertile
Fig. 4  Forest plot illustrating predictors of serum retinol in the lower 
retinol tertile. The standardized β and corresponding confidence 
intervals were derived from linear regression models adjusted for age 
and sex. CRP C-reactive protein, apo apolipoprotein, KTR kynure-
nine to tryptophan ratio, PAr pyridoxic acid to pyridoxal + pyridoxal-























































Associations of biomarkers with serum retinol 
 3rd tertile
Fig. 5  Forest plot illustrating predictors of serum retinol in the upper 
retinol tertile. The standardized β and corresponding confidence 
intervals were derived from linear regression models adjusted for age 
and sex. CRP C-reactive protein, apo apolipoprotein, KTR kynure-
nine to tryptophan ratio, PAr pyridoxic acid to pyridoxal + pyridoxal-
5-phosphate ratio, BMI body mass index
European Journal of Nutrition 
1 3
Compliance with Ethical Standards 
Conflict of interest The authors declare that they have no conflicts of 
interest.
Open Access This article is distributed under the terms of the Crea-
tive Commons Attribution 4.0 International License (http://creat iveco 
mmons .org/licen ses/by/4.0/), which permits unrestricted use, distribu-
tion, and reproduction in any medium, provided you give appropriate 
credit to the original author(s) and the source, provide a link to the 
Creative Commons license, and indicate if changes were made.
References
 1. Blomhoff R, Blomhoff HK (2006) Overview of retinoid metab-
olism and function. J Neurobiol 66(7):606–630. https ://doi.
org/10.1002/neu.20242 
 2. Chen W, Chen G (2014) The roles of vitamin A in the regula-
tion of carbohydrate, lipid, and protein metabolism. J Clin Med 
3(2):453–479. https ://doi.org/10.3390/jcm30 20453 
 3. Patel S, Vajdy M (2015) Induction of cellular and molecular 
immunomodulatory pathways by vitamin A and flavonoids. Expert 
Opin Biol Ther 15(10):1411–1428. https ://doi.org/10.1517/14712 
598.2015.10663 31
 4. Olsen T, Vinknes KJ, Svingen GFT, Pedersen ER, Tell GS, Blom-
hoff R, Drevon CA, Ueland PM, Midttun O, Refsum H, Nygard 
OK (2017) Cardiovascular disease risk associated with serum 
apolipoprotein B is modified by serum vitamin A. Atherosclero-
sis. https ://doi.org/10.1016/j.ather oscle rosis .2017.07.020
 5. Olsen T, Vinknes KJ, Svingen GF, Pedersen ER, Dhar I, Tell 
GS, Blomhoff R, Ueland PM, Midttun O, Refsum H, Nygard OK 
(2018) The risk association of plasma total homocysteine with 
acute myocardial infarction is modified by serum vitamin A. Eur 
J Prev Cardiol 25(15):1612–1620. https ://doi.org/10.1177/20474 
87318 78858 7
 6. Ballew C, Bowman BA, Sowell AL, Gillespie C (2001) Serum 
retinol distributions in residents of the United States: third 
National Health and Nutrition Examination Survey, 1988–
1994. Am J Clin Nutr 73(3):586–593. https ://doi.org/10.1093/
ajcn/73.3.586
 7. Michaelsson K, Lithell H, Vessby B, Melhus H (2003) Serum reti-
nol levels and the risk of fracture. N Engl J Med 348(4):287–294. 
https ://doi.org/10.1056/NEJMo a0211 71
 8. Bakker MF, Peeters PH, Klaasen VM, Bueno-de-Mesquita HB, 
Jansen EH, Ros MM, Travier N, Olsen A, Tjonneland A, Overvad 
K, Rinaldi S, Romieu I, Brennan P, Boutron-Ruault MC, Per-
quier F, Cadeau C, Boeing H, Aleksandrova K, Kaaks R, Kuhn 
T, Trichopoulou A, Lagiou P, Trichopoulos D, Vineis P, Krogh V, 
Panico S, Masala G, Tumino R, Weiderpass E, Skeie G, Lund E, 
Quiros JR, Ardanaz E, Navarro C, Amiano P, Sanchez MJ, Buck-
land G, Ericson U, Sonestedt E, Johansson M, Sund M, Travis 
RC, Key TJ, Khaw KT, Wareham N, Riboli E, van Gils CH (2016) 
Plasma carotenoids, vitamin C, tocopherols, and retinol and the 
risk of breast cancer in the European Prospective Investigation 
into Cancer and Nutrition cohort. Am J Clin Nutr 103(2):454–464. 
https ://doi.org/10.3945/ajcn.114.10165 9
 9. Stephensen CB, Gildengorin G (2000) Serum retinol, the acute 
phase response, and the apparent misclassification of vitamin A 
status in the third National Health and Nutrition Examination Sur-
vey. Am J Clin Nutr 72(5):1170–1178. https ://doi.org/10.1093/
ajcn/72.5.1170
 10. Kanagasabai T, Alkhalaqi K, Churilla JR, Ardern CI (2018) The 
association between metabolic syndrome and serum concentra-
tions of micronutrients, inflammation, and oxidative stress outside 
of the clinical reference ranges: a Cross-Sectional Study. Metab 
Syndr Relat Disord. https ://doi.org/10.1089/met.2018.0080
 11. Min KB, Min JY (2014) Relation of serum vitamin A levels 
to all-cause and cause-specific mortality among older adults 
in the NHANES III population. Nutr Metab Cardiovasc Dis 
24(11):1197–1203. https ://doi.org/10.1016/j.numec d.2014.06.004
 12. Park SE, Park CY, Sweeney G (2015) Biomarkers of insulin 
sensitivity and insulin resistance: past, present and future. Crit 
Rev Clin Lab Sci 52(4):180–190. https ://doi.org/10.3109/10408 
363.2015.10234 29
 13. Mody N (2017) Alterations in vitamin A/retinoic acid homeosta-
sis in diet-induced obesity and insulin resistance. Proc Nutr Soc 
76(4):597–602. https ://doi.org/10.1017/S0029 66511 70010 69
 14. Liu Y, Zhong Y, Chen H, Wang D, Wang M, Ou JS, Xia M (2017) 
Retinol-binding protein-dependent cholesterol uptake regulates 
macrophage foam cell formation and promotes atherosclerosis. 
Circulation 135(14):1339–1354. https ://doi.org/10.1161/CIRCU 
LATIO NAHA.116.02450 3
 15. Olson JA (1984) Serum levels of vitamin A and carotenoids as 
reflectors of nutritional status. J Natl Cancer Inst 73(6):1439–1444
 16. Jing J, Isoherranen N, Robinson-Cohen C, Petrie I, Kestenbaum 
BR, Yeung CK (2016) Chronic kidney disease alters vitamin A 
homeostasis via effects on hepatic RBP4 protein expression and 
metabolic enzymes. Clin Transl Sci 9(4):207–215. https ://doi.
org/10.1111/cts.12402 
 17. Rubin LP, Ross AC, Stephensen CB, Bohn T, Tanumihardjo SA 
(2017) Metabolic effects of inflammation on vitamin A and carot-
enoids in humans and animal models. Adv Nutr 8(2):197–212. 
https ://doi.org/10.3945/an.116.01416 7
 18. Svingen GF, Ueland PM, Pedersen EK, Schartum-Hansen H, Seif-
ert R, Ebbing M, Loland KH, Tell GS, Nygard O (2013) Plasma 
dimethylglycine and risk of incident acute myocardial infarc-
tion in patients with stable angina pectoris. Arterioscler Thromb 
Vasc Biol 33(8):2041–2048. https ://doi.org/10.1161/ATVBA 
HA.113.30171 4
 19. Ebbing M, Bleie O, Ueland PM, Nordrehaug JE, Nilsen DW, 
Vollset SE, Refsum H, Pedersen EK, Nygard O (2008) Mortality 
and cardiovascular events in patients treated with homocysteine-
lowering B vitamins after coronary angiography: a randomized 
controlled trial. JAMA 300(7):795–804. https ://doi.org/10.1001/
jama.300.7.795
 20. Windelberg A, Arseth O, Kvalheim G, Ueland PM (2005) Auto-
mated assay for the determination of methylmalonic acid, total 
homocysteine, and related amino acids in human serum or plasma 
by means of methylchloroformate derivatization and gas chroma-
tography-mass spectrometry. Clin Chem 51(11):2103–2109. https 
://doi.org/10.1373/clinc hem.2005.05383 5
 21. Midttun O, McCann A, Aarseth O, Krokeide M, Kvalheim G, 
Meyer K, Ueland PM (2016) Combined measurement of 6 fat-
soluble vitamins and 26 water-soluble functional vitamin markers 
and amino acids in 50 μL of serum or plasma by high-throughput 
mass spectrometry. Anal Chem 88(21):10427–10436. https ://doi.
org/10.1021/acs.analc hem.6b023 25
 22. Midttun O, Ueland PM (2011) Determination of vitamins A, D 
and E in a small volume of human plasma by a high-throughput 
method based on liquid chromatography/tandem mass spectrom-
etry. Rapid Commun Mass Spectrom 25(14):1942–1948. https ://
doi.org/10.1002/rcm.5073
 23. Midttun O, Kvalheim G, Ueland PM (2013) High-throughput, 
low-volume, multianalyte quantification of plasma metabolites 
related to one-carbon metabolism using HPLC–MS/MS. Anal 
Bioanal Chem 405(6):2009–2017. https ://doi.org/10.1007/s0021 
6-012-6602-6
 European Journal of Nutrition
1 3
 24. Midttun O, Hustad S, Ueland PM (2009) Quantitative profiling 
of biomarkers related to B-vitamin status, tryptophan metabo-
lism and inflammation in human plasma by liquid chromatogra-
phy/tandem mass spectrometry. Rapid Commun Mass Spectrom 
23(9):1371–1379. https ://doi.org/10.1002/rcm.4013
 25. Ulvik A, Midttun O, Pedersen ER, Eussen SJ, Nygard O, Ueland 
PM (2014) Evidence for increased catabolism of vitamin B-6 dur-
ing systemic inflammation. Am J Clin Nutr 100(1):250–255. https 
://doi.org/10.3945/ajcn.114.08319 6
 26. Ueland PM, McCann A, Midttun O, Ulvik A (2017) Inflam-
mation, vitamin B6 and related pathways. Mol Aspects Med 
53:10–27. https ://doi.org/10.1016/j.mam.2016.08.001
 27. Mjelva OR, Svingen GFT, Pedersen EKR, Seifert R, Kvaloy 
JT, Midttun O, Ueland PM, Nordrehaug JE, Nygard O, Nilsen 
DWT (2018) Fibrinogen and neopterin is associated with future 
myocardial infarction and total mortality in patients with sta-
ble coronary artery disease. Thromb Haemost 118(4):778–790. 
https ://doi.org/10.1055/s-0038-16299 12
 28. Nes M, Frost Andersen L, Solvoll K, Sandstad B, Hustvedt BE, 
Lovo A, Drevon CA (1992) Accuracy of a quantitative food 
frequency questionnaire applied in elderly Norwegian women. 
Eur J Clin Nutr 46(11):809–821
 29. Hjartaker A, Andersen LF, Lund E (2007) Comparison of diet 
measures from a food-frequency questionnaire with measures 
from repeated 24 h dietary recalls. The Norwegian Women and 
Cancer Study. Public Health Nutr 10(10):1094–1103. https ://
doi.org/10.1017/s1368 98000 77028 72
 30. Andersen LF, Tomten H, Haggarty P, Lovo A, Hustvedt BE 
(2003) Validation of energy intake estimated from a food fre-
quency questionnaire: a doubly labelled water study. Eur J Clin 
Nutr 57(2):279–284. https ://doi.org/10.1038/sj.ejcn.16015 19
 31. Chen J, He J, Ogden LG, Batuman V, Whelton PK (2002) Rela-
tionship of serum antioxidant vitamins to serum creatinine in 
the US population. Am J Kidney Dis 39(3):460–468. https ://doi.
org/10.1053/ajkd.2002.31389 
 32. Granado-Lorencio F, Blanco-Navarro I, Perez-Sacristan B, Mil-
lan I, Donoso-Navarro E, Silvestre-Mardomingo RA (2013) 
Determinants of fat-soluble vitamin status in patients aged 
65 years and over. Eur J Clin Nutr 67(12):1325–1327. https ://
doi.org/10.1038/ejcn.2013.198
 33. Danquah I, Dobrucky CL, Frank LK, Henze A, Amoako YA, 
Bedu-Addo G, Raila J, Schulze MB, Mockenhaupt FP, Sch-
weigert FJ (2015) Vitamin A: potential misclassification of vita-
min A status among patients with type 2 diabetes and hyperten-
sion in urban Ghana. Am J Clin Nutr 102(1):207–214. https ://
doi.org/10.3945/ajcn.114.10134 5
 34. Amelio I, Cutruzzola F, Antonov A, Agostini M, Melino 
G (2014) Serine and glycine metabolism in cancer. Trends 
Biochem Sci 39(4):191–198. https ://doi.org/10.1016/j.
tibs.2014.02.004
 35. Brosnan JT, Brosnan ME (2006) The sulfur-containing amino 
acids: an overview. J Nutr 136(6 Suppl):1636S–1640S
 36. Mosharov E, Cranford MR, Banerjee R (2000) The quantita-
tively important relationship between homocysteine metabolism 
and glutathione synthesis by the transsulfuration pathway and its 
regulation by redox changes. Biochemistry 39(42):13005–13011
 37. Yamada C, Kondo M, Kishimoto N, Shibata T, Nagai Y, Iman-
ishi T, Oroguchi T, Ishii N, Nishizaki Y (2015) Association 
between insulin resistance and plasma amino acid profile in 
non-diabetic Japanese subjects. J Diabetes Investig 6(4):408–
415. https ://doi.org/10.1111/jdi.12323 
 38. Ntzouvani A, Nomikos T, Panagiotakos D, Fragopoulou E, 
Pitsavos C, McCann A, Ueland PM, Antonopoulou S (2017) 
Amino acid profile and metabolic syndrome in a male Medi-
terranean population: a cross-sectional study. Nutr Metab 
Cardiovasc Dis 27(11):1021–1030. https ://doi.org/10.1016/j.
numec d.2017.07.006
 39. Elshorbagy AK, Kozich V, Smith AD, Refsum H (2012) Cysteine 
and obesity: consistency of the evidence across epidemiologic, 
animal and cellular studies. Curr Opin Clin Nutr Metab Care 
15(1):49–57. https ://doi.org/10.1097/MCO.0b013 e3283 4d199 f
 40. Elshorbagy AK, Valdivia-Garcia M, Refsum H, Butte N (2012) 
The association of cysteine with obesity, inflammatory cytokines 
and insulin resistance in Hispanic children and adolescents. PLoS 
One 7(9):e44166. https ://doi.org/10.1371/journ al.pone.00441 66
 41. Rowling MJ, McMullen MH, Schalinske KL (2002) Vitamin A 
and its derivatives induce hepatic glycine N-methyltransferase and 
hypomethylation of DNA in rats. J Nutr 132(3):365–369
 42. Ozias MK, Schalinske KL (2003) All-trans-retinoic acid rapidly 
induces glycine N-methyltransferase in a dose-dependent manner 
and reduces circulating methionine and homocysteine levels in 
rats. J Nutr 133(12):4090–4094
 43. el Yaagoubi M, Hachad H, Leh H, Siest G, Wellman M (1995) 
γ-Glutamyltransferase expression during all-trans retinoic acid-
induced differentiation of hematopoietic cell lines. FEBS Lett 
369(2–3):183–186
 44. Lu SC (2009) Regulation of glutathione synthesis. Mol Aspects 
Med 30(1–2):42–59. https ://doi.org/10.1016/j.mam.2008.05.005
 45. Giral P, Jacob N, Dourmap C, Hansel B, Carrie A, Bruckert E, 
Girerd X, Chapman MJ (2008) Elevated gamma-glutamyltrans-
ferase activity and perturbed thiol profile are associated with 
features of metabolic syndrome. Arterioscler Thromb Vasc Biol 
28(3):587–593. https ://doi.org/10.1161/ATVBA HA.107.15789 1
 46. Shimizu H, Kiyohara Y, Kato I, Kitazono T, Tanizaki Y, Kubo 
M, Ueno H, Ibayashi S, Fujishima M, Iida M (2004) Relationship 
between plasma glutathione levels and cardiovascular disease in a 
defined population: the Hisayama study. Stroke 35(9):2072–2077. 
https ://doi.org/10.1161/01.STR.00001 38022 .86509 .2d
 47. Bono, Tejon G, Flores-Santibanez F, Fernandez D, Rosemblatt M, 
Sauma D (2016) Retinoic acid as a modulator of T cell immunity. 
Nutrients. https ://doi.org/10.3390/nu806 0349
 48. Kushiyama A, Nakatsu Y, Matsunaga Y, Yamamotoya T, Mori 
K, Ueda K, Inoue Y, Sakoda H, Fujishiro M, Ono H, Asano T 
(2016) Role of uric acid metabolism-related inflammation in the 
pathogenesis of metabolic syndrome components such as ath-
erosclerosis and nonalcoholic steatohepatitis. Mediat Inflamm 
2016:8603164. https ://doi.org/10.1155/2016/86031 64
 49. Ford ES, Choi HK (2013) Associations between concentrations 
of uric acid with concentrations of vitamin A and beta-carotene 
among adults in the United States. Nutr Res 33(12):995–1002. 
https ://doi.org/10.1016/j.nutre s.2013.08.008
 50. Choi WJ, Ford ES, Curhan G, Rankin JI, Choi HK (2012) Inde-
pendent association of serum retinol and beta-carotene levels with 
hyperuricemia: a national population study. Arthritis Care Res 
(Hoboken) 64(3):389–396. https ://doi.org/10.1002/acr.20692 
 51. George J, Struthers AD (2009) Role of urate, xanthine oxidase and 
the effects of allopurinol in vascular oxidative stress. Vasc Health 
Risk Manag 5(1):265–272
 52. Mawson AR (1984) Hypervitaminosis A toxicity and gout. Lancet 
1(8387):1181
 53. Fuchs D, Avanzas P, Arroyo-Espliguero R, Jenny M, Consue-
gra-Sanchez L, Kaski JC (2009) The role of neopterin in athero-
genesis and cardiovascular risk assessment. Curr Med Chem 
16(35):4644–4653
 54. Taleb S (2016) Inflammation in atherosclerosis. Arch Cardiovasc 
Dis 109(12):708–715. https ://doi.org/10.1016/j.acvd.2016.04.002
 55. Hodge AM, Simpson JA, Fridman M, Rowley K, English DR, 
Giles GG, Su Q, O’Dea K (2009) Evaluation of an FFQ for assess-
ment of antioxidant intake using plasma biomarkers in an ethni-
cally diverse population. Public Health Nutr 12(12):2438–2447. 
https ://doi.org/10.1017/s1368 98000 90055 39
European Journal of Nutrition 
1 3
 56. Jarvinen R, Knekt P, Seppanen R, Heinonen M, Aaran RK (1993) 
Dietary determinants of serum beta-carotene and serum retinol. 
Eur J Clin Nutr 47(1):31–41
 57. Li D, Sinclair AJ, Mann NJ, Turner A, Ball MJ (2000) Selected 
micronutrient intake and status in men with differing meat intakes, 
vegetarians and vegans. Asia Pac J Clin Nutr 9(1):18–23
 58. Barbosa FP, Luna RC, Monteiro MG, Asciutti LS, de Oliveira 
RS, Diniz Ada S, Lima RT, Benigna MJ, de Moraes RM, Costa 
MJ, Goncalves Mda C (2013) Relationship between hemoglobin, 
serum retinol and habitual meat consumption in the elderly: a 
population-based study. Arch Gerontol Geriatr 57(1):60–65. https 
://doi.org/10.1016/j.archg er.2013.01.004
 59. Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano 
AL, Cooney MT, Corra U, Cosyns B, Deaton C, Graham I, Hall, 
Hobbs FDR, Lochen ML, Lollgen H, Marques-Vidal P, Perk J, 
Prescott E, Redon J, Richter DJ, Sattar N, Smulders Y, Tiberi M, 
van der Worp HB, van Dis I, Verschuren WMM, Binno S, Group 
ESCSD (2016) European Guidelines on cardiovascular disease 
prevention in clinical practice: the Sixth Joint Task Force of the 
European Society of Cardiology and Other Societies on Cardio-
vascular Disease Prevention in Clinical Practice (constituted by 
representatives of 10 societies and by invited experts)Developed 
with the special contribution of the European Association for Car-
diovascular Prevention and Rehabilitation (EACPR). Eur Heart J 
37(29):2315–2381. https ://doi.org/10.1093/eurhe artj/ehw10 6
 60. Holvik K, Ahmed LA, Forsmo S, Gjesdal CG, Grimnes G, Samu-
elsen SO, Schei B, Blomhoff R, Tell GS, Meyer HE (2015) No 
increase in risk of hip fracture at high serum retinol concentra-
tions in community-dwelling older Norwegians: the Norwegian 
Epidemiologic Osteoporosis Studies. Am J Clin Nutr. https ://doi.
org/10.3945/ajcn.115.11052 8
 61. Mondul AM, Yu K, Wheeler W, Zhang H, Weinstein SJ, Major 
JM, Cornelis MC, Mannisto S, Hazra A, Hsing AW, Jacobs KB, 
Eliassen H, Tanaka T, Reding DJ, Hendrickson S, Ferrucci L, 
Virtamo J, Hunter DJ, Chanock SJ, Kraft P, Albanes D (2011) 
Genome-wide association study of circulating retinol levels. Hum 
Mol Genet 20(23):4724–4731. https ://doi.org/10.1093/hmg/ddr38 
7
 62. Gueguen S, Leroy P, Gueguen R, Siest G, Visvikis S, Herbeth B 
(2005) Genetic and environmental contributions to serum retinol 
and alpha-tocopherol concentrations: the Stanislas Family Study. 
Am J Clin Nutr 81(5):1034–1044
